Us Congress 2023-2024 Regular Session

Us Congress House Bill HB5957

Introduced
10/13/23  
Refer
10/25/23  

Caption

Robin Danielson Menstrual Product and Intimate Care Product Safety Act of 2023

Impact

If enacted, HB5957 would authorize the National Institutes of Health (NIH) to conduct research focused on identifying risks linked to substances in menstrual and intimate care products. The bill emphasizes the necessity for thorough safety examinations for products typically entering the market with minimal regulatory oversight. It aims to foster better health outcomes by generating data that could lead to more informed consumer choices and potential regulatory actions concerning product safety in the future. The result of this research could lead to enhanced consumer protection laws at both the state and federal levels.

Summary

House Bill 5957, formally known as the 'Robin Danielson Menstrual Product and Intimate Care Product Safety Act of 2023', seeks to amend the Public Health Service Act by establishing a comprehensive program of research on the risks posed by prevalent chemicals in menstrual and intimate care products. Identifying contaminants such as dioxins, phthalates, and undisclosed fragrance chemicals, the bill aims at understanding their potential health impacts, specifically concerning reproductive health and long-term safety for users. It highlights the lack of existing research systematic enough to ensure the safety of these widely used products, underscoring concerns regarding exposure over many years.

Contention

While many legislators and advocacy groups support the intent of HB5957 to improve public health, some may express concerns regarding implications for manufacturers and the potential for increased regulation. The bill’s focus on chemical safety can raise questions about the liability of manufacturers in terms of disclosures and product approvals. Further, discussions may arise about equity in health, as certain populations disproportionately affected by these chemical exposures may not have had access to the protections this bill aims to establish.

Companion Bills

No companion bills found.

Previously Filed As

US HB10230

Good Samaritan Menstrual Products Act

US HB7905

STAMP Act of 2024 Stop Taxes Against Menstrual Products Act of 2024

US HB3646

Menstrual Equity For All Act of 2023

US HB6109

PILLS Act Producing Incentives for Long-term production of Lifesaving Supply of Medicine Act

US HB3644

Menstrual Equity For All Act of 2025

US HR1248

Recognizing the impact the stigmatization of menstruation has on the lives of women, girls, and people who menstruate, and expressing support for the designation of the month of May as "National Menstrual Health Awareness Month".

US HB4576

Safeguarding Domestic Energy Production and Independence Act of 2023

US SB104

Defending Domestic Produce Production Act of 2023

US HB1396

PILLS Act Producing Incentives for Long-term production of Lifesaving Supply of medicine Act

US HR351

Recognizing the impact the stigmatization of menstruation has on the lives of women, girls, and people who menstruate, and expressing support for the designation of the month of May as "National Menstrual Health Awareness Month".

Similar Bills

CA AB367

Menstrual products.

CA AB230

Menstrual products: Menstrual Equity for All Act of 2021.

NJ A2437

Requires ingredients of menstrual products to be listed on package.

NJ S3643

Requires ingredients of menstrual products to be listed on package.

CA SB59

Battery electric vehicles: bidirectional capability.

HI SB2821

Relating To Menstrual Equality.

CA AB246

Product safety: menstrual products: perfluoroalkyl and polyfluoroalkyl substances.

HI HB2249

Relating To Menstrual Equality.